Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets-Reference-Cited by-同舟云学术

Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets

Published:2021-01 Issue: Volume:Volume 14 Page:315-324
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Grossmann Nico C^ORCID,Schuettfort Victor M,Pradere Benjamin^ORCID,Moschini Marco,Quhal Fahad,Mostafaei Hadi,Soria Francesco,Katayama Satoshi,Laukhtina Ekaterina,Mori Keiichiro,Sari Motlagh Reza,Poyet Cédric,Abufaraj Mohammad^ORCID,Karakiewicz Pierre I,Shariat Shahrokh F,D’Andrea David

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference60 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

2. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

3. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

4. Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

5. ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer;Frontiers in Medicine;2023-11-15

2. New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy;Clinical and Translational Oncology;2023-02-06

3. Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection;Journal of Gastrointestinal Oncology;2023-02

4. Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy;Urologic Oncology: Seminars and Original Investigations;2021-11

5. Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder;Cancers;2021-05-14